Key facts
- Eventum Orthopaedics’s last known valuation is $22.4M (Mar 2025).
- It has raised $10.4M; the latest was Later Stage VC ($4.8M) in Mar 2025.
- Notable investors include Mercia Ventures, Northern Powerhouse Investment Fund, Shackleton Ventures, Enterprise Ventures.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Eventum Orthopaedics
- ·The full record, as it builds
Funding rounds
No funding rounds for Eventum Orthopaedics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Eventum Orthopaedics
Developer of a medical technology designed to improve the outcome for patients who have undergone knee replacement operations. The company's sensor technology focuses on the positioning of the kneecap, which plays a significant role in the overall function of the knee, enabling healthcare professionals to improve their decision-making and make real-time measurements of the knee area during the operation.
- Sector
- Healthcare
- HQ
- Leeds, United Kingdom
- Founded
- 2020
- Employees
- 10
- Website
- eventumortho.com/
- Ownership
- Privately Held (backing)
Eventum Orthopaedics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Eventum Orthopaedics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Eventum Orthopaedics in its N-PORT filings yet. We sweep new filings monthly.